Castrioto, A.
Schmitt, E.
Anheim, M.
Meoni, S.
Klinger, H.
Sourd, D.
Pelissier, P.
Lhommée, E.
Bichon, A.
Tranchant, C.
Moro, E.
Fraix, V.
Thobois, S.
Krack, P.
Funding for this research was provided by:
French Parkinson Association
UCB
Article History
Received: 12 November 2024
Accepted: 5 April 2025
First Online: 24 April 2025
Competing interests
: A.C. received a research grant from Medtronic (to the institution), reimbusement for scientific meetings from ABBVIE, honoraria for lectures from MDS and ABBVIE, M.A.: Abbvie, Merz, Aguettant, Biogen Pharmaceuticals, Ipsen Pharma, Linde, Ever Pharma, Medtronic. S.M. received research grant support from Medtronic, Newronika, Grenoble Alpes University, Huntington’s Disease Network. V.F.: Consultancy fees from AbbVie France, Honorarium from MEDTRONIC. C.T.: AbbVie, IPSEN, Lynde. E.M. is an associated editor of npj Parkinson ́s Disease. E.M. has received honoraria from Medtronic for consulting services. She has also received restricted research grants from the Grenoble Alpes University, France Parkinson, IPSEN and Abbott. S.T. received grant from ANR, Neuratris, Boston Scientific, personal fees for conferences from Merz, Aguettant, NHC, for board/consulting from ABBVIE, Medtronic, Boston Scientific, for meetings from MDS and ABBVIE. P.K.: reports research or educational grants from Swiss National Science Foundation, ROGER DE SPOELBERCH Foundation, Fondation Louis-Jeantet, Carigest, Institut National de la Santé et de la Recherche Médicale, France Parkinson, Edmond Safra Philantropic Foundation, Bertarelli Foundation, Annemarie Opprecht Foundation, Parkinson Schweiz, Michael J Fox Foundation, Aleva Neurotherapeutics, Boston Scientific, Medtronic, St. Jude Medical, GE Healthcare, Idorsia, UCB, all paid to employing institutions; lecturing fees to employing institution from Boston Scientific, Bial, Advisis; travel expenses to scientific meetings from Boston Scientific, Zambon, Abbvie, Merz Pharma (Schweiz) AG. E.S., H.K., E.L., A.B., D.S., P.P.: declare no competing interests.